We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Suitcase Laboratory Set to Improve Ebolavirus Control

By LabMedica International staff writers
Posted on 19 Jan 2015
Print article
Image: Diagnostics-in-a-Suitcase contains all the equipment and reagents necessary to detect the Ebolavirus within 15 minutes (Photo courtesy of Karin Tilch/DPZ).
Image: Diagnostics-in-a-Suitcase contains all the equipment and reagents necessary to detect the Ebolavirus within 15 minutes (Photo courtesy of Karin Tilch/DPZ).
A portable laboratory for the diagnosis of Ebolavirus has been developed and the new method is six to ten times faster than the current one, equally sensitive and will be tested in Africa soon.

Currently, laboratory tests for Ebolavirus use a technique called real-time polymerase chain reaction (PCR) that looks for the genome signature of the virus in the sample, and although PCR machines are becoming smaller, they are not suitable for remote locations with no electricity and refrigeration.

Scientists at the German Primate Center (DPZ; Göttingen, Germany) have developed Diagnostics-in-a-Suitcase, which contains all reagents and equipment to detect the Ebolavirus within 15 minutes at point-of-need. Moreover, the mobile suitcase laboratory will be operated by an integrated solar panel and a power pack.

The Diagnostics-in-a-Suitcase is based on the Recombinase Polymerase Amplification (RPA) technology developed by TwistDx Ltd. (Cambridge, UK). This method was adapted to be used for Ebolavirus diagnosis by scientists at the University Medical Center Göttingen (Germany). RPA is as sensitive as PCR, but extremely rapid and works at a constant temperature, meaning no rapid heat-cycling equipment is required. Furthermore, reagents used in the RPA test are cold chain independent, which allows them to be used and transported at ambient temperature.

Christiane Stahl-Hennig, DMV, who heads DPZ's Unit of Infection Models, said, “The early detection of Ebola infected patients will lead to a more effective virus control since medical staff can identify and isolate confirmed Ebola cases more rapidly. The Diagnostics-in-a-Suitcase will therefore contribute to a better management during the Ebola-outbreak.” The idea is the Diagnostics-in-a-Suitcase will enable the rapid detection of Ebolavirus not only out in the field but also at other points of need such as airports and quarantine stations.

Related Links:

German Primate Center 
TwistDx Ltd.
University Medical Center Göttingen


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: The new method could reduce undiagnosed cancer cases in less-developed regions (Photo courtesy of 123RF)

New Method Offers Sustainable Approach to Universal Metabolic Cancer Diagnosis

Globally, more than one billion people suffer from a high rate of missed disease diagnosis, highlighting the urgent need for more precise and affordable diagnostic tools. Such tools are especially crucial... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.